CT影像组学特征与胰腺导管腺癌基因型及间质含量的关联
该回顾性研究纳入35例接受胰腺导管腺癌切除术且同意靶向测序的患者,从术前CT提取影像组学特征预测基因型与间质含量。影像组学模型与SMAD4状态及基因改变数量相关,间质含量预测模型R²为0.731、均方根误差19.5。
要点
- 术前CT影像组学模型可预测PDAC的SMAD4状态及基因改变数量。
- 影像组学线性回归模型预测肿瘤间质含量R²=0.731、均方根误差19.5。
- 基因改变数量是总生存期的唯一显著预测因子(p=0.016)。
核心结论
- 在PDAC中,术前CT影像组学分析可预测SMAD4状态和肿瘤间质含量,提示可切除PDAC的影像特征与潜在肿瘤生物学相关,并具有未来精准医学的潜力。
研究设计与样本
- 回顾性研究,纳入2015年4月至2016年6月间连续接受PDAC切除术且既往同意靶向测序方案的患者35例。
- 原发肿瘤已知PDAC驱动基因(KRAS、TP53、CDKN2A、SMAD4)突变状态通过靶向DNA测序确定,结果经免疫组化验证。
- 从术前CT扫描提取肿瘤影像组学特征,用于预测基因型和间质含量。
关键影像表现/征象
- 基因组和免疫组化分析显示KRAS改变34例(97%),CDKN2A表达改变29例(83%),SMAD4改变16例(46%),TP53改变29例(83%)。
诊断标准与关键数值
- 由影像组学特征构建的模型显示与SMAD4状态及基因改变数量存在关联。
- 线性回归分析中间质含量预测模型R²值为0.731,均方根误差为19.5。
- 基因改变数量是总生存期的唯一显著预测因子(p=0.016)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to investigate the relationship between CT imaging phenotypes and genetic and biological characteristics in pancreatic ductal adenocarcinoma (PDAC).
METHODS: In this retrospective study, consecutive patients between April 2015 and June 2016 who underwent PDAC resection were included if previously consented to a targeted sequencing protocol. Mutation status of known PDAC driver genes (KRAS, TP53, CDKN2A, and SMAD4) in the primary tumor was determined by targeted DNA sequencing and results were validated by immunohistochemistry (IHC). Radiomic features of the tumor were extracted from the preoperative CT scan and used to predict genotype and stromal content.
RESULTS: The cohort for analysis consisted of 35 patients. Genomic and IHC analysis revealed alterations in KRAS in 34 (97%) patients, and changes in expression of CDKN2A in 29 (83%), SMAD4 in 16 (46%), and in TP53 in 29 (83%) patients. Models created from radiomic features demonstrated associations with SMAD4 status and the number of genes altered. The number of genes altered was the only significant predictor of overall survival (p = 0.016). By linear regression analysis, a prediction model for stromal content achieved an R2 value of 0.731 with a root mean square error of 19.5.
CONCLUSIONS: In this study, we demonstrate that in PDAC SMAD4 status and tumor stromal content can be predicted using radiomic analysis of preoperative CT imaging. These data show an association between resectable PDAC imaging features and underlying tumor biology and their potential for future precision medicine.
引用
- Attiyeh MA, Chakraborty J, McIntyre CA, et al. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2019. PMID: 31243486. doi:10.1007/s00261-019-02112-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。